ATM and cancer: Indeed, 21 of 24 BRAF and ATM mutated colorectal cancers (87.5%) in TCGA are MSI or POLE subtype while among BRAF mutated, in ATM wild type cancers only 55.3% belong to these subtypes (Fisher’s exact test p = 0.01).